Search results
28 sie 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL multi-dose vial (3 doses per vial) presentation).
Guidance below summarizes basic storage, preparation, scheduling, administration, and dosage for all 2024–25 Pfizer-BioNTech COVID-19 vaccine products.
16 wrz 2024 · Pfizer-BioNTech COVID-19 vaccine 2024-2025 formula is authorized for people ages 6 months through 11 years. Comirnaty is approved for people age 12 and older. The vaccines that help protect against COVID-19 are safe and effective based on clinical trials and continued monitoring.
11 gru 2020 · COMIRNATY ® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech. It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older; It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:
22 sie 2024 · Individuals 5 years through 11 years of age regardless of previous vaccination are eligible to receive a single dose of the updated, authorized Moderna or Pfizer-BioNTech COVID-19 vaccines;...
23 sie 2021 · COMIRNATY (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech. • It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older. • It is also authorized under EUA to be administered to: o prevent COVID-19 in individuals 12 through 15 years, and.
19 kwi 2024 · Quick Summary. Vaccine name: BNT162b2, marketed as Comirnaty. Design type: mRNA. Population: Adults and children 12 years of age and older. Dose number: Originally 2, 21 days apart, with a...
